Nausea Induced by Radiation of the Dorsal Vagal Complex for Benign Brain Tumors (NausiCAA)
Characterization of Nausea Induced by Radiation of the Dorsal Vagal Complex in the Context of Benign Brain Tumors (NausiCAA)
University Hospital, Bordeaux
100 participants
May 20, 2022
OBSERVATIONAL
Conditions
Summary
Patients irradiated to the brain frequently experience nausea. The dorsal vagal complex (DVC) area is a specific brainstem zone and has been identified as likely responsible for nausea. Existing clinical studies show correlation between dose to the DVC and nausea, but they concern tumors of the airways and upper digestive tract, where there are many confounding factors. The aim of this study is to establish a ling between radiation dose to the DVC and nausea. Defining a dose threshold to the DVC will allow radiation oncologists to optimize radiation dose distribution and reduce nausea in patients.
Eligibility
Inclusion Criteria3
- More than 18 years old
- With benign brain tumor
- Irradiated with conventional fractionation (1,8-2Gy/fraction)
Exclusion Criteria6
- History of brain radiation
- History of head and neck radiation
- Demencia
- Concurrent chemotherapy
- Nausea at the time of inclusion
- Anti-nausea treatment : corticosteroids, metoclopramide, setrons, other
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Radiation
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06506578